home.social

#mdspatients — Public Fediverse posts

Live and recent posts from across the Fediverse tagged #mdspatients, aggregated by home.social.

  1. Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

    Geron Corporation Oral presentation from pooled analyses of the IMerge population suggests that treatment-emerg…
    #NewsBeep #News #Medication #CA #Canada #eligiblepatients #GeronCorporation #Health #IMerge #imetelstat #LR-MDS #MDSpatients #posterpresentations #RYTELO #treatmentoptions
    newsbeep.com/ca/334044/

  2. europesays.com/ie/222138/ Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS #Éire #EligiblePatients #GeronCorporation #Health #IE #IMerge #imetelstat #Ireland #LRMDS #MDSPatients #Medication #PosterPresentations #RYTELO #TreatmentOptions

  3. Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

    Geron Corporation Oral presentation from pooled analyses of the IMerge popula…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #eligiblepatients #GeronCorporation #Health #IMerge #imetelstat #LR-MDS #MDSpatients #posterpresentations #RYTELO #treatmentoptions
    newsbeep.com/us/337199/

  4. Geron Corporation Presents New Data at ASH 2025 Highlighting the Relationship Between Treatment-Emergent Cytopenias and Clinical Benefit of RYTELO® (Imetelstat) in Lower-Risk MDS

    Geron Corporation Oral presentation from pooled analyses of the IMerge popula…
    #NewsBeep #News #US #USA #UnitedStates #UnitedStatesOfAmerica #Medication #eligiblepatients #GeronCorporation #Health #IMerge #imetelstat #LR-MDS #MDSpatients #posterpresentations #RYTELO #treatmentoptions
    newsbeep.com/us/337199/